Repair is expensive. Rebuilding tissue, calming inflammation, laying down new collagen — every one of those processes runs on cellular energy, and when that energy is depleted, repair slows no matter how good the signal.
The Renewal pairs KLOW's four-system repair work with NAD+ & MOTS-c, which restores the mitochondrial capacity that repair depends on. The work and the fuel to do it.
Two vials, six peptides. One handles the repair work across four different systems. The other restores the cellular machinery that makes repair possible.
Four repair peptides in a single vial, each working a different pathway. BPC-157 drives structural healing in tendon, ligament, muscle, and the gut wall. TB-500 works systemically, helping cells reach injury sites. GHK-Cu activates collagen and elastin renewal for skin and connective tissue. KPV calms inflammatory signaling at the immune level. Together they cover more ground than any single peptide can.
NAD+ is the coenzyme every cell uses to convert nutrients into usable energy, and it declines steadily with age. MOTS-c is a mitochondrial-derived peptide that improves how efficiently the mitochondria themselves operate. Paired, they address cellular energy from two directions — the raw currency and the machinery that spends it.
Every repair process in the body is metabolically expensive. Synthesizing collagen, rebuilding damaged tissue, mounting and then resolving an inflammatory response, replacing the lining of the gut — all of it consumes cellular energy at a rate well above baseline.
This is why repair slows with age even when the signals are intact. NAD+ declines. Mitochondrial efficiency drops. The instructions to rebuild still arrive, but the cells receiving them have less capacity to act. The Renewal addresses both halves — KLOW supplies the repair signaling across four systems, while NAD+ and MOTS-c restore the energetic capacity to carry it out.
The name is the idea. Renewal isn't one thing being fixed — it's the whole system being restored to a state where it can repair itself properly again. This stack works on both what gets rebuilt and what does the rebuilding.
This stack tends to work on two tracks — energy and inflammation shift relatively early, while structural and visible changes build steadily across the protocol.
NAD+ is central to how cells convert nutrients into usable energy, and levels fall considerably with age. Restoring it, alongside MOTS-c's effect on mitochondrial efficiency, tends to show up as steadier energy through the day rather than a stimulant-style lift — less afternoon flatness, more capacity for physical and mental work.
BPC-157 and TB-500 are the most researched pairing for connective tissue healing, working particularly well in tendon and ligament where blood supply is limited and healing is normally slow. With cellular energy restored alongside them, that repair work has the metabolic capacity it needs to actually proceed.
GHK-Cu is one of the body's most potent natural signals for collagen and elastin production. Clients typically notice improved skin firmness, softened fine lines, and more even texture across a protocol — changes that come from structural protein actually being rebuilt rather than surface treatment. Hair thickness and joint cushioning often follow with continued cycling.
BPC-157 was originally identified through gastric proteins and has a particular affinity for the gut, helping restore the mucosal lining and reduce intestinal permeability. KPV adds a second, immune-level layer of anti-inflammatory support directed at the gut wall. Improved digestive comfort is often among the earlier changes people report.
KPV modulates NF-κB, one of the primary switches governing the body's inflammatory response. Rather than suppressing immunity broadly, it helps recalibrate an overactive response — which makes this stack relevant for chronic low-grade inflammation, mast cell activation, and post-viral recovery where immune dysregulation is part of the picture.
MOTS-c influences how cells handle glucose and metabolic stress, while NAD+ is required by the enzymes involved in DNA repair and cellular maintenance. GHK-Cu has separately been shown to shift gene expression toward repair pathways. Together these represent the longevity-oriented layer of the stack — working on the systems that govern how well the body maintains itself over time.
A general sense of how this stack tends to unfold. Individual response varies — your clinician will set expectations specific to your goals and starting point.
Dosing and scheduling are set during your consultation. Both vials are pre-mixed and ready to use, but the protocol — how much, how often, and how the two components are sequenced and cycled — is determined by your clinician based on your goals, history, and response.
This stack is cycled, not continuous. KLOW contains GHK-Cu, a copper peptide, and copper-containing protocols are run in defined cycles with planned breaks rather than taken indefinitely. Your clinician will structure that schedule as part of your protocol. Avoid additional copper supplements while using this stack unless your provider specifically directs otherwise.
Most effects are mild and appear only in the first week or two. Contact your provider if anything feels significant, unusual, or doesn't resolve on its own.
The Renewal is coordinated with clinical oversight. Your consultation establishes whether this stack fits your goals, and sets the protocol, dosing, and cycle schedule specific to you.
Book a ConsultationFor educational purposes only. Many compounds referenced on this site are investigational and not FDA-approved.
Always consult a qualified healthcare provider before starting any peptide regimen.
© 2026 Bespoke Biology